When it comes to Covid-19, the biggest risk isn’t rare side effects from vaccines. The biggest risk is not being vaccinated.
OMRF receives three grants to study autoimmune disease
The federal grants will support the work of two OMRF scientists who are investigating different aspects of autoimmune disease: Judith James, M.D., Ph.D., and Joan Merrill, M.D.
Oblato acquires all rights to glioblastoma drug from OMRF
Oblato, Inc., has acquired all rights from OMRF to OKN-007, an investigational drug for the treatment of a deadly form of brain cancer.
OMRF enters into a license agreement with Shanghai RAAS Blood Products
OMRF has entered a license agreement with Shanghai RAAS Blood Products for development of novel hemophilia treatment.
Researchers identify gene associated with lupus
The gene, NCF1, was known by researchers, but it had not previously been linked to lupus